These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1704395)

  • 1. Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells.
    Hammond SA; Obah E; Stanhope P; Monell CR; Strand M; Robbins FM; Bias WB; Karr RW; Koenig S; Siliciano RF
    J Immunol; 1991 Mar; 146(5):1470-7. PubMed ID: 1704395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
    Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
    J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins.
    Ferris RL; Buck C; Hammond SA; Woods AS; Cotter RJ; Takiguchi M; Igarashi Y; Ichikawa Y; Siliciano RF
    J Immunol; 1996 Jan; 156(2):834-40. PubMed ID: 8543840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
    Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE
    J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
    Johnson RP; Trocha A; Buchanan TM; Walker BD
    J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes.
    Dadaglio G; Leroux A; Langlade-Demoyen P; Bahraoui EM; Traincard F; Fisher R; Plata F
    J Immunol; 1991 Oct; 147(7):2302-9. PubMed ID: 1717555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
    J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
    Sijts AJ; Ossendorp F; Mengedé EA; van den Elsen PJ; Melief CJ
    J Immunol; 1994 Jan; 152(1):106-16. PubMed ID: 8254184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.
    Lieberman J; Fabry JA; Kuo MC; Earl P; Moss B; Skolnik PR
    J Immunol; 1992 May; 148(9):2738-47. PubMed ID: 1374097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection.
    Manca F; De Berardinis P; Fenoglio D; Ombra MN; Li Pira G; Saverino D; Autiero M; Lozzi L; Bracci L; Guardiola J
    Eur J Immunol; 1996 Oct; 26(10):2461-9. PubMed ID: 8898961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.